Prevenying vision loss in a mouse model of Leber Congenital Amaurosis by engineered tRNA
Pattnaik, B. R.; Akyuz, E.; Shahi, P. K.; Gissot, L.; Saneh, A. A.; Sinha, D.; Hanstad, G.; Kabra, M. R.; Zepeda, M. A.; Gamm, D. M.; Young, S. M.; Ahern, C. A.
Show abstract
Premature termination codons (PTCs) are associated with rare genetic disorders. Inducing targeted read-through of these nonsense mutations presents a potential therapeutic strategy for modifying disease outcomes. We previously reported that one such PTC, W53X, in the KCNJ13 gene causes blindness and Leber congenital amaurosis type-16 (LCA-16) due to loss of function of the inwardly rectifying potassium channel 7.1 (Kir7.1). Here, we present the proof of concept of a therapeutic approach based on anticodon-engineered transfer RNA (ACE-tRNA). The ACE-tRNA encodes the amino acid tryptophan (Trp) and suppresses the W53X PTC, restoring full-length protein expression. We used helper-dependent adenovirus (HDAd) to deliver the ACE-tRNATrp.UAG (tRNATrp.UAG) and rescue Kir7.1 function and physiology in patient-specific human induced pluripotent stem cell-derived retinal pigment epithelium (hiPSC-RPE) cells. Furthermore, in a W53X mouse model of LCA16, HDAd delivery of tRNATrp.UAG resulted in durable restoration of vision as measured by retinography. This study provides the first example of the therapeutic application of ACE-tRNA for treating an inherited form of blindness.
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
- Optineurin-facilitated axonal mitochondria delivery promotes neuroprotection and axon regeneration 94%
- Tectonic Complex Impedes Diffusion through the Ciliary Transition Zone to Ensure Proper Sorting of Membrane Proteins 94%
- Brain development mutations in the β-tubulin TUBB result in defective ciliogenesis 94%
Similar papers in this journal
- Dual CRALBP isoforms unveiled: iPSC-derived retinal modelling and AAV2/5-RLBP1 gene transfer raise considerations for effective therapy 95%
- A novel multiplex RNAi therapy simultaneously targets Hif1a and Hif2a to defy retinal degeneration in two models of AMD 95%
- AAV NRF2 Gene Therapy Preserves Retinal Structure and Function in Rodent Models of Oxidative Damage 94%
Similar papers in this journal
- Optogenetic tools for inducing organelle membrane rupture 92%
- Targeted delivery of rhodopsin's assembled core is required for outer segment extension in mouse rod photoreceptors 92%
- Distinct alpha-synuclein strains derived from Parkinson's disease patient tissues trigger differential inclusion pathology in a novel biosensor cell model 92%
Similar papers in this journal
- PRPF8-associated retinitis pigmentosa variant induces human neural retina-autonomous photoreceptor defects 93%
- The polymicrogyria-associated GPR56 promoter preferentially drives gene expression in developing GABAergic neurons in common marmosets 93%
- Expression of a Barhl1a reporter in subsets of retinal ganglion cells and commissural neurons of the developing zebrafish brain 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.